Vice President/TA Head, Oncology Regulatory Affairs

Merck & Co. is seeking an experienced and knowledgeable Vice President/TA Head of Oncology Regulatory Affairs to provide strategic direction and oversight for the development and implementation of global regulatory strategies for oncology products. This individual will lead and manage a team of regulatory professionals responsible for the global regulatory activities of Merck & Co. in the oncology space and will be a critical partner in the development and commercialization of oncology products.The ideal candidate must have a broad understanding of the global regulatory environment, excellent communication and project management skills, and a demonstrated ability to build relationships with internal and external stakeholders. The successful candidate will have a minimum of 10 years of experience in the regulatory affairs field, with at least 5 years in a leadership capacity. Experience in oncology regulatory affairs is highly desired. We are seeking an individual who is passionate about the development of oncology products, has a collaborative approach and enjoys working in a dynamic, fast-paced environment.

According to JobzMall, the average salary range for a Vice President/TA Head, Oncology Regulatory Affairs in Rahway, NJ 07065, USA is $150,000 to $175,000 per year. This figure can vary depending on the individual's experience, qualifications, and other factors.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.